SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.
Molecular Weight:
416.39
Purity:
98.61%
CAS Number:
[115621-95-9]
Formula:
C23H27Cl2N3
Target:
Platelet aggregation|||PAFR
T28740
* VAT and and shipping costs not included. Errors and price changes excepted
